David Langleben
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Pulmonary Hypertension Research and Treatments
- Respiratory Support and Mechanisms
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Pulmonary Hypertension Research and Treatments 138
- Respiratory Support and Mechanisms 7
- Blood properties and coagulation 3
- Co-authors
- Robert D. Levy (6 shared papers)Lewis J. Rubin (9 shared papers)Nazzareno Galiè (14 shared papers)David B. Badesch (5 shared papers)Gérald Simonneau (18 shared papers)Duncan John Stewart (11 shared papers)Robyn J. Barst (8 shared papers)Maurice Beghetti (3 shared papers)
- Journals
- CHEST Journal (21 papers)European Respiratory Journal (8 papers)Canadian Journal of Cardiology (8 papers)The Journal of Heart and Lung Transplantation (8 papers)Pulmonary Circulation (7 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
David Langleben
165 papers receiving 16.4k citations
David Langleben's Hit Papers
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 13.7k
- Internal Medicine 169
- Cardiology and Cardiovascular Medicine 1.2k
- Pathology and Forensic Medicine 709
- Physiology 1k
Countries citing papers authored by David Langleben
This map shows the geographic impact of David Langleben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Langleben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Langleben more than expected).
Fields of papers citing papers by David Langleben
This network shows the impact of papers produced by David Langleben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Langleben. The network helps show where David Langleben may publish in the future.
Co-authors
The 25 scholars most cited alongside David Langleben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension Hit paper breakdown → | 1996 | 2205 |
| 2 | Updated Clinical Classification of Pulmonary Hypertension Hit paper breakdown → | 2009 | 1669 |
| 3 | Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension Hit paper breakdown → | 1993 | 1522 |
| 4 | Clinical classification of pulmonary hypertension Hit paper breakdown → | 2004 | 1467 |
| 5 | Definitions and Diagnosis of Pulmonary Hypertension Hit paper breakdown → | 2013 | 1414 |
| 6 | Riociguat for the Treatment of Pulmonary Arterial Hypertension Hit paper breakdown → | 2013 | 1094 |
| 7 | Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease Hit paper breakdown → | 2000 | 876 |
| 8 | Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease? Hit paper breakdown → | 1991 | 827 |
| 9 | Sitaxsentan Therapy for Pulmonary Arterial Hypertension Hit paper breakdown → | 2003 | 581 |
| 10 | Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update Hit paper breakdown → | 2018 | 424 |
| 11 | 2006 | 388 | |
| 12 | 1997 | 267 | |
| 13 | 1985 | 254 | |
| 14 | 2015 | 175 | |
| 15 | 2013 | 165 | |
| 16 | 2003 | 160 | |
| 17 | 1995 | 159 | |
| 18 | 2005 | 154 | |
| 19 | 1993 | 142 | |
| 20 | 2017 | 125 |
About David Langleben
David Langleben is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Hematology, Internal Medicine and Physiology, having authored 174 papers that have together received 17.5k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (138 papers), Respiratory Support and Mechanisms (7 papers), Nitric Oxide and Endothelin Effects (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Systemic Sclerosis and Related Diseases (4 papers), Blood properties and coagulation (3 papers), TGF-β signaling in diseases (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (13.7k citations), Internal Medicine (169 citations), Cardiology and Cardiovascular Medicine (1.2k citations), Pathology and Forensic Medicine (709 citations) and Physiology (1k citations). David Langleben has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Robert D. Levy, Lewis J. Rubin, Nazzareno Galiè, David B. Badesch, Gérald Simonneau, Duncan John Stewart, Robyn J. Barst, Maurice Beghetti, Zhi‐Cheng Jing and Stuart Rich. Their work appears in journals such as CHEST Journal, European Respiratory Journal, Canadian Journal of Cardiology, The Journal of Heart and Lung Transplantation and Pulmonary Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.